Clinical Trials
60 trialsTAILORx
National Cancer Institute (NCI)
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
PRART
Weill Medical College of Cornell University
ABCD RT
NRG Oncology
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Alliance for Clinical Trials in Oncology
OLIGAMI
Tokyo Medical and Dental University
ProHer
Hoffmann-La Roche
SOFT
ETOP IBCSG Partners Foundation
Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PRATO
Weill Medical College of Cornell University
KEYNOTE-756
Merck Sharp & Dohme LLC
Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery
Mayo Clinic
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Eastern Cooperative Oncology Group
STARS
Trans Tasman Radiation Oncology Group
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Alliance for Clinical Trials in Oncology
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Radiotherapy for Extracranial Oligometastatic Breast Cancer
ChineseAMS
CASA
ETOP IBCSG Partners Foundation
Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost
NYU Langone Health
Tamoxifen in Treating Women With High-Risk Breast Cancer
Canadian Cancer Trials Group
A Phase â…¢ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
ChineseAMS
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
NSABP Foundation Inc
Z0011-China
Shandong Cancer Hospital and Institute
CALOR
ETOP IBCSG Partners Foundation
Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer
Ain Shams University
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
Radiation Therapy Oncology Group
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
Virginia Commonwealth University
Study of Arimidex and Radiotherapy Sequencing
Fudan University
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
National Cancer Institute (NCI)
Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
National Cancer Institute (NCI)
Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
National Cancer Institute (NCI)
Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
National Cancer Institute (NCI)
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
National Cancer Institute (NCI)
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
National Cancer Institute (NCI)
Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
National Cancer Institute (NCI)
AMAROS
European Organisation for Research and Treatment of Cancer - EORTC
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Chemotherapy Plus Surgery in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy
National Cancer Institute (NCI)
Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer
National Cancer Institute (NCI)
Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
National Cancer Institute (NCI)
Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer
National Cancer Institute (NCI)
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
10-93
ETOP IBCSG Partners Foundation
S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
SWOG Cancer Research Network